Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome

Inflammatory breast cancer (IBC) represents a rare but aggressive and lethal form of locally advanced breast cancer (LABC) and frequently with HER-2 neu overexpressed or amplified. We retrospectively identified 16 newly diagnosed HER-2/neu-positive IBC patients who were treated with preoperative tra...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dawood, Shaheenah, Gong, Yun, Broglio, Kristine, Buchholz, Thomas A., Woodward, Wendy, Lucci, Anthony, Valero, Vicente, Gonzalez-Angulo, Ana M., Hortobagyi, Gabriel N., Cristofanilli, Massimo
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3097300/
https://ncbi.nlm.nih.gov/pubmed/20626396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-4741.2010.00953.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares